Cytoskeleton, Inc. has the widest line of small G-protein related products on the market. Cytoskeleton sells purified proteins, a large number of Biochem Kits™ to assay the biology and biochemistry of small G-proteins as well as antibodies to G-proteins and related proteins. See each individual product page for examples of uses. Bulk quantities of all these proteins are available for substantial discounts.
For more information about Small G-proteins please click the About tab above.
The Ras superfamily of small GTPases consist of more than 150 members, which based on their sequence homology, are divided into several subfamilies such as Rho, Ras, Ran, Rab, Arf and Rad/Rem/Gem/Kir. This group of small GTPases serve as binary switches cycling between GDP-bound inactive and GTP-bound active state (1,2). The regulatory proteins for this switch include guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and guanine nucleotide dissociation inhibitors (GDIs) (1,2).
The Rho subfamily
The Rho family of small GTPases consists of at least 20 members, the most extensively characterized of which are the Rac1, RhoA and Cdc42 proteins (3). In common with all other small GTPases, the Rho proteins act as molecular switches that transmit cellular signals through an array of effector proteins. This family is involved in a wide range of cellular responses, including cytoskeletal reorganization (4-5), regulation of transcription (6), cell migration (7), cellular transformation and metastasis (8).
The Ras subfamily
There are approximately 10 members of this subfamily split between Ras, Ral and Rap proteins. Ras proteins function in the Raf/ERK signaling pathway which controls proliferation and differentiation. Ral proteins function in the early steps of endocytosis, whereas Rap’s function as antagonist of Ras and they are located to the late endosomal and early lysosomal compartments.
The Ran subfamily
The Ran proteins regulate nuclear transport of macromolecules, and in the cell cycle checkpoint from DNA replication to entry into mitosis.
The Rab subfamily
One of the largest subfamilies of small G-proteins, the Rab proteins regulate the flow of vesicles from the ER to the Golgi and onto the plasma membrane. They are ubiquitously expressed and are highly abundant.
The Rad/Rem/Gem/Kir subfamily
Members of this subfamily (RGK subfamily) have wide ranging functions such as controlling cardiac hypertrophy, inhibiting insulin-stimulated glucose uptake in myocyte and adipocyte cell lines, as well as inhibiting voltage dependent calcium channels by binding to the b-subunit (9).
The Arf subfamily
The Arf family consists of Arf proteins and Arf-like proteins (Arl’s) (10). As a general rule the Arf proteins help regulate vesicle trafficking and membrane fusion in functions such as nuclear membrane fusion, negative regulation of Golgi vesicle transport, and plasma membrane invagination. This family is the most divergent of the small G-proteins being equally related to heterotrimeric G-protein family.
Small G-protein measurement
There are several methods used to measure Small G-proteins, these include a) measurement of the active "GTP-bound" form in extracts and in situ, b) measuring total Small G-protein levels, c) Exchange activity from GTP to GDP and vice versa, and d) the endogenous GTPase rate. Cytoskeleton provides kits for all these assays (e.g. BK124, BK100, BK100 and BK105).
Guanine exchange factors
GEFs catalyze the exchange of GDP for GTP to generate the active state of small GTPases in response to extracellular signals. In order to facilitate the exchange, the GEFs must bind to the GDP bound GTPases, destabilize the GDP-GTPase complex, and then stabilize a nucleotide free reaction intermediate. Because of the high intracellular ratio of GTP to GDP, the released GDP is replaced with GTP, leading to release of GEFs from the complex and activation of the GTPase (1,2). Many GEF proteins have been identified as oncogenes and are involved in human disease such as cancer. Interestingly, the expression of GEF protein is tissue or cell type specific, providing a therapeutic potential for cancer treatment (2, 13).
Recently developed fluorescence analogs of guanine nucleotides have greatly improved the technical ability to define the real time exchange reaction of GEFs, including kinetic and thermodynamic properties, eliminating the need for traditional radioactive labeling method (14, 15). This fluorescence based assay takes advantage of the spectroscopic difference between bound and unbound fluorescent analogs to guanine nucleotides and thus is able to monitor the states of small GTPases (14, 15). One of most widely used fluorescent analogs is mant (N-methylanthraniloyl) fluorophores. Excitation of mant flurophore at 360nm (+/-10nm) gives a fluorescence emission at 440nm (+/-20nm). Once bound to GTPases, the fluorophore emission intensity increases dramatically approximately 2 fold. Therefore, the enhancement of fluorescent intensity in the presence of small GTPases and GEFs will reflect the respective GEF activities of known or unknown proteins.
Cytoskeleton Inc. has developed a Mant fluorophore based GEF assay suitable for both 96-well and 384-well format. This assay can be applied to multiple research purposes such as characterizing the GEFs and identifying GEF inhibitors in a high throughput screen format. This kit contains human Cdc42, Rac1 and RhoA proteins and the GEF domain of Dbs as a positive control GEF for Cdc42 (Fig. 1) and RhoA. Dbs shows extremely low GEF activity for Rac1 (see Fig.2 and ref. 4). Interestingly, it was reported that human Dbs can activate Rac1 in a FRET based assay (16).
Legend: The small GTPases Cdc42 (Cat# CD01) and the human Dbs protein (Cat# GE01) were expressed as His-tagged proteins in E. coli and purified on a nickel affinity column. The reactions were conducted in a 96 well black flat bottom half area plate (Corning Cat# 3686) format (150 µl reaction volumes). Each reaction contains 1 µM GTPases, 50 µg/ml bovine serum albumin (BSA), 20 mM Tris pH 7.5, 50 mM NaCl, 10 mM MgCl2, and 0.8 µM mant-GTP with or without the presence of 0.5 µM human Dbs(DH/PH) protein. Reactions were measured in a Tecan Spectrofluor plus fluorimeter(lex=360nm, lem=460nm). Readings were taken at 20°C every 30 seconds for a total reaction time of 30 minutes.
GTPase Activating Proteins
The balance of the GTP to GDP bound state underlies the switch mechanism as they turn from an activated (GTP form) to inactive state (GDP form). The balance of GTP to GDP bound states is controlled by catalytic proteins that either increase the rate of exchange of GDP for GTP (GEFs), increase the GTPase activity (GAPs), or prevent the exchange of GDP (GDIs). Recently it has been shown that the GAP family of proteins is large (70 members) and potentially important for changing a cell from a normal to disease status (see review in ref. 17).
GAP activity can be reduced by deletion or mutation in cells; in this case the small GTPase targeted by the GAP has an extended time in the active GTP state, in essence creating a permanently active state. For example the ability of Rho GTPase to control axonal guidance is exemplified in the finding that mutations of a Rho-GAP can lead to mental retardation (18,19). In cancer, mutated Ras-GAPs (NF1 gene) have been shown to cause neurofibromatosis (20,21), and mutated Rheb-GAP has been shown to cause tuberous sclerosis complex (21).
Although some GAPs are known to have GAP activity, the majority of assumed GAP proteins have only been implicated by homology to contain GAP activity. Cytoskeleton Inc. is facilitating the exploration of this field by introducing the GAP Assay Kit (Cat. # BK105). Several small GTPase proteins (Ras, RhoA, CDC42 and Rac1) are included such that the researcher can screen the small G-proteins for GAP like activity which is usually small G-protein specific i.e. RhoGAP or Ras GAP. It is likely that new domain information will identify other small G-protein GAPs which have not been apparent. In addition the new assay kits are easily adapted for High Throughput Screen format which allows development of ligands for pharmaceutical studies. Please inquire for bulk reagent quotes if you are considering a screening application (email@example.com).
The reagents in this kit have been optimized to enable high activity from your GAP protein such that you can detect the enhanced GTPase of a small G-protein through a simple absorbance based detection method. The small G-protein is incubated in the presence of GAP protein (Rho GAP is the control protein included in this kit), GTP and the optimized buffer. The overall GTPase activity of small G-proteins is composed of two components which limit the activity; these are a) endogenous GTPase activity and b) GDP dissociation rate. The endogenous activity can be enhanced by the addition of a suitable GAP protein, whereas the dissociation rate can be enhanced by buffer optimization.
Figure 2. p50 RhoGAP activity measured by GTP hydrolysis by RhoA and Rac1 protein
Method: The small GTPases RhoA (Cat. # RH01), Rac1 (Cat. # RC01) and the human p50 RhoGAP protein (Cat. # GAS01) were expressed and purified from E. coli and are available as separate items from Cytoskeleton Inc. The reactions were conducted in a half area clear 96 well plate (Corning Cat. # 3696) format (40 µl reaction volumes). Each reaction contains +/- 5 µg RhoA or +/- Rac1, +/- 8 µg p50 RhoGAP domain and 200 µM GTP in Reaction Buffer. Sample 1 contained Rac1 only, sample 2 contained Rac1 and p50 RhoGAP, sample 3 contained RhoA only, sample 4 contained RhoA and p50 RhoGAP, and sample 5 contained p50 RhoGAP alone. Reactions were incubated at 37ºC for 20 min followed by the addition 120 µl of CytoPhos reagent for 10 min to determine the phosphate generated by the hydrolysis of GTP.
Cytoskeleton's products have been cited hundreds of times over the past 18 years. A select few are described here, for more citations on individual products please use the "Citations" tab on each individual product page.
Howe and Addison, 2012. RhoB controls endothelial cell morphogenesis in part via negative regulation of RhoA. Vascular Cell. v 4, p 1.
Zhou et al., 2012. HSV-mediated gene transfer of C3 transferase inhibits Rho to promote axonal regeneration. Exp. Neurol. http://dx.doi.org/10.1016/j.expneurol.2012.06.016.
Bi, Y. and Williams, J. A. (2005). A role for Rho and Rac in secretagogue induced amylase release by pancreatic acini. Am. J. Physiol. 289, C22-33.
Borm, B., Requardt, R. P., Herzog, V. and Kirfel, G. (2005). Membrane ruffles in cell migration: indicators of inefficient lamellipodia adhesion and compartments of actin filament reorganization. Exp. Cell Res. 302, 83-95.
Giordano Pula and Alastair W. Poole. Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin a2b1. Platelets, 2008, Vol. 19, No. 3, Pages 199-210 , DOI: 10.1080/09537100701777303
Akio Shimizu and Akiko Mammoto et al. ABL2/ARG Tyrosine Kinase Mediates SEMA3F-induced RhoA Inactivation and Cytoskeleton Collapse in Human Glioma Cells. Journal of Biological Chemistry, 283, 27230-27238. DOI: 10.1074/jbc.M804520200
Zhang, X. F., Schaefer, A. W., Burnette, D. T., Schoonderwoert, V. T. and Forscher, P. (2003). Rho-dependent contractile responses in the neuronal growth cone are independent of classical peripheral retrograde actin flow. Neuron 40, 931-944.
Gallo, G., Yee, H. F., Jr. and Letourneau, P. C. (2002). Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility. J. Cell Biol. 158, 1219-1228. 34
Cytoskeleton provides multiple options for measuring Rho protein in extracts from cells or tissue samples. Measuring Rho protein is typically discussed in terms of total and active (GTP-bound) levels of Rho.
To measure total Rho levels, we offer the RhoA ELISA (Cat. # BK150) which has a linear range of 1 to 30 ng and a CV = 4%. An alternative is to use the anti-RhoA antibody to probe a blot of extracts, although this method is less accurate, it is useful for 1 to 5 samples.
To examine the levels of active Rho in extracts, Cytoskeleton offers the GLISA series of Activation assay kits. These kit contain all the reagents necessary to perform the assay from lysis buffer through to protein assay and signal developing reagents. The kits are in 12 x 8-well strip format which allows you to use just 2 or 4 wells at a time. The results are highly reproducible and more accurate (CV = 13%, plus 8 fold linear range) than the conventional pulldown kits described next. Cytoskeleton also offers pulldown assays (e.g., Cat. # BK036) which are packaged with all the necessary reagents, buffers and glutathione beads coupled to a Rho effector protein to complete the assay, in this format activated Rho levels are analyzed by western blot analysis which has CV's from 15 to 30% and a 3 fold linear range.
Conveniently, the GLISA and ELISA complement each other because the same lysate can be used with both kits. The G-LISA activation assays are often a better option than the traditional pull-downs as G-LISAs offer increased sensitivity, truly quantitative results, and the ability to process up to 96 samples at one time in less than 3 hours.
Active Rho levels in cells and tissues can be modulated by our G-switch line of reagents. Cytoskeleton offers indirect (Cat. # CN01) and direct (Cat. # CN03) Rho activators as well as a Rho inhibitor (Cat. # CT04). The direct activator and inhibitor are cell-permeable and robustly activate or inhibit RhoA activity, respectively, in a multitude of cell lines.
Cytoskeleton, Inc. offers a wide variety of kits and products that allow a thorough investigation of how a protein of interest affects small G-protein localization and function. We have highly-specific antibodies to RhoA (Cat. # ARH03), Rac1 (Cat. # ARC03) and Cdc42 (Cat. # ACD03) that can be used to examine changes in GTPase localization or expression levels. We also offer a Total RhoA ELISA kit to quantify total RhoA levels with the most sensitive and accurate assay currently available (Cat. # BK150). To measure small GTPase activation levels, we offer the G-LISA activation assays for RhoA (Cat. # BK124), Rac1 (Cat. # BK128), Rac1,2,3 (Cat. # BK125), Cdc42 (Cat. # BK127) and RalA (Cat. # BK129). Results with these 96-well format kits (presented as 12 x 8-well strips) are highly accurate and reproducible. Also the traditional pulldown assays are available for Ras (Cat. # BK008), Cdc42 (Cat. # BK034), Rac1 (Cat. # BK035), RhoA (Cat. # BK036) and RalA (Cat. # BK040).
To further examine how the protein of interest can affect GTPase activity, we also offer our G-switch line of small G-protein modulators. With these reagents, GTPase activity levels in cells and tissues can be activated or inhibited. Cytoskeleton offers indirect Rho (Cat. # CN01) and Rac/Cdc42 (Cat. # CN02) activators and direct Rho (Cat. # CN03) and Rho/Rac/Cdc42 (Cat. # CN04) activators as well as a Rho inhibitor (Cat. # CT04). The direct activators and inhibitor are cell-permeable and robustly activate or inhibit GTPase activity, respectively, in a multitude of cell lines.
To measure how your protein affects the signal transduction pathways involved in activating (GEFs) and deactivating (GAPs) GTPases, Cytoskeleton offers a RhoGEF Exchange Assay biochem kit (Cat. # BK100) and a RhoGAP Assay biochem kit (Cat. # BK105), respectively. The RhoGEF assay measures nucleotide exchange on GTPases using a fluorescent nucleotide analog while GAP activity is assessed by measuring the amount of inorganic phosphate produced as a result of hydrolysis of GTP to GDP by the GTPase.
If you are using microinjection as a tool to study your protein of interest in cells, Cytoskeleton offers purified, biologically-active and tagged GTPases (wild-type, dominant-negative and constitutively-active) that can be micro-injected into cells to study how your protein affects the GTPase.